Chipotle opens door to beef treated with antibiotics
As cattle herds continue to decline and food prices tick up, the restaurant chain is finding that sticking to its ideals is tough.
The company, which prides itself on working with producers that treat animals with "dignity and respect," clarified that it's specifically leaning toward beef from cattle treated with drugs for illnesses. It still won't buy meat produced from cows treated with antibiotics to promote weight gain or prevent disease.
As Bloomberg News noted, the company's strict ideals are facing tough economic realities. For one thing, beef production is projected to hit a 21-year low next year, and as a result Chipotle is having trouble finding sufficient supplies of naturally produced beef. If Chipotle bought beef from cattle treated for sickness with antibiotics, its available supplies will increase.
"Many experts, including some of our ranchers, believe that animals should be allowed to be treated if they are ill and remain in the herd," said Steve Ells, Chipotle founder and co-CEO, in a press release. "We are certainly willing to consider this change, but we are continuing to evaluate what’s best for our customers, our suppliers and the animals.”
Idealism has paid off for Chipotle. Its shares have soared nearly 700% since 2006. Sales have more than doubled in the four years ended in 2012. The company recently reported better-than-expected quarterly results and gave bullish earnings guidance for the rest of the year.
The use of antibiotics in livestock is widespread. One published report estimated that 70% of all antibiotics produced are consumed by cattle, even though experts have warned about the growth in drug-resistant infections. The FDA has also begun taking a tougher line on antibiotic use in cattle.
"Last year, the agency said farmers must have a prescription to get antibiotics for their livestock and the drugs can only be given when medically necessary," Bloomberg says.
The National Cattlemen's Beef Association said it had no comment on Chipotle's potential policy change.
--Jonathan Berr does not own shares of the listed stocks. Follow him on Twitter @jdberr.
It's a real cop-out to take a stand and draw the line, and then make up excuses so you can cross that line. Why continue to play these stupid games? Either you buy beef that has been injected with antibiotics or you don't. Is John Kerry the CEO of Chipotle now - "Uh, I voted against the antibiotic beef before I voted for it."
Cows taste good, with or without penicillin.
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
A basic income policy can actually ensure a decent standard of living for everyone.
- People left $500,000 in coins at airports last year
- How your driving can affect your credit
- Obamacare projected to cost hundreds of billions less
- November jobs report: Winners and losers
- Student loan debt climbs for 5th year in a row
- Wall Street finally notices Bitcoin
- Part-time workers hurt by on-call system
- 5 myths about late payments and your FICO scores
- Auto loan interest rates hit record low
[BRIEFING.COM] A solid November employment report translated into a solid day of gains for the major averages. While there was some talk that the encouraging job growth raised the odds of the Fed announcing a tapering at its December meeting, the message of the markets today was either that it didn't believe there would be a tapering this month or that it doesn't fear a tapering this month.
It was just one day, yet there was ample meaning wrapped up in the connection that the 10-yr ... More
More Market News
The Fed may start tapering in just a few months. Here are a few of the likely winners and losers.